M. S. Istomina
M. S. Istomina has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Yana G. Toropova
Almazov National Medical Research Centre
4 shared publications - Oleg. N. Demidov
Sirius University of Science and Technology
3 shared publications - Aleksandr Valerievich Shvidchenko
Ioffe Institute, Department of Solid State Electronics
2 shared publications - Alexey Petukhov
V.A. Almazov National Medical Research Center
2 shared publications - Alina E. Ershova
Division of Immunobiology and Biomedicine, Sirius University of Science and Technology, 354349 Sirius, Russia
2 shared publications - Andrey N. Aleshin
Laboratory of Nonequilibrium Processes in Semiconductors, Ioffe Institute, 26 Politekhnicheskaya, Saint Petersburg 194021, Russia
2 shared publications
Latest Publications
- Open Access
- 2 July 2025
- Published by SCEEMP in Regulatory Research and Medicine Evaluation
- Vol. 15 (3) , 289-300
Methods for Preclinical Assessment of the Efficacy of Anticancer Medicines in vivo (Review)
INTRODUCTION. The main risk to the clinical translatability of preclinical results for anticancer medicinal products is posed by the difficulty of simulating clinical conditions in an experimental model. With only 5% of product candidates proving clinically effective, the search for new approaches to the preclinical development of anticancer medicinal products is currently an active area of research in medicine.AIM. This study aimed to provide methodological support for planning experiments with modelling of neoplastic processes through analysis and classification of the methods used in preclinical studies of the efficacy of anticancer medicinal products in vivo.DISCUSSION. This article reviews the development of animal tumour models and the selection of cell lines and their testing for tumourigenicity and viability on a step-by-step basis. According to the study results, imaging systems, vital staining, and fluorescence- and luminescence-based methods can be used to assess the efficacy of anticancer medicinal products in both solid tumour models and haematological malignancy models. The article presents a schematic representation of the main types of mouse cancer models. However, no single animal species is universally suitable for in vivo cancer modelling. Researchers selecting models and considering their advantages and disadvantages should pay special attention to the similarity of disease mechanisms in animal models and humans at the tissue and molecular level, keeping in mind the aims of their research.CONCLUSIONS. The results of this comparative analysis of methods for preclinical efficacy evaluation of anticancer medicinal products are essential for designing experimental studies and ensuring the reliability of the results obtained. Choosing the correct research method will increase the chances of obtaining experimental data that can be successfully translated into clinical practice.
- 2 July 2025
- Published by SCEEMP in Regulatory Research and Medicine Evaluation
- Vol. 15 (3) , 289-300
Open AccessMethods for Preclinical Assessment of the Efficacy of Anticancer Medicines in vivo (Review)
INTRODUCTION. The main risk to the clinical translatability of preclinical results for anticancer medicinal products is posed by the difficulty of simulating clinical conditions in an experimental model. With only 5% of product candidates proving clinically effective, the search for new approaches to the preclinical development of anticancer medicinal products is currently an active area of research in medicine.AIM. This study aimed to provide methodological support for planning experiments with modelling of neoplastic processes through analysis and classification of the methods used in preclinical studies of the efficacy of anticancer medicinal products in vivo.DISCUSSION. This article reviews the development of animal tumour models and the selection of cell lines and their testing for tumourigenicity and viability on a step-by-step basis. According to the study results, imaging systems, vital staining, and fluorescence- and luminescence-based methods can be used to assess the efficacy of anticancer medicinal products in both solid tumour models and haematological malignancy models. The article presents a schematic representation of the main types of mouse cancer models. However, no single animal species is universally suitable for in vivo cancer modelling. Researchers selecting models and considering their advantages and disadvantages should pay special attention to the similarity of disease mechanisms in animal models and humans at the tissue and molecular level, keeping in mind the aims of their research.CONCLUSIONS. The results of this comparative analysis of methods for preclinical efficacy evaluation of anticancer medicinal products are essential for designing experimental studies and ensuring the reliability of the results obtained. Choosing the correct research method will increase the chances of obtaining experimental data that can be successfully translated into clinical practice.
- 1 January 2024
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 94 (1) , 129-137
Synthesis of PLGA Nanoparticles Filled with Indocyanine Green and Warfarin for Biomedical Application, Study of Their Physical and Chemical Characteristics, Natural Biodistribution and Penetration through the Hematoplacental Barrier
Warfarin, the drug containing the chemical substance of the same name, currently is not prescribed to pregnant women because it crosses the hematoplacental barrier. This issue can be eliminated by incorporating it into polymer nanospheres. In this study, we have proposed a synthesis method and have characterized the prepared lactic-glycolic acid copolymer (PLGA) nanospheres containing warfarin (WAF) and the fluorescent dye Indocyanine Green (ICG). The optimal concentration of WAF has been established. The dependence of the nanospheres size on the reagents ratio has been investigated. The zeta potential values have been obtained, indicating high colloidal stability of the suspensions. The introduction of ICG into the nanospheres has afforded the data on their natural biodistribution. It has been found by means of fluorescence tomography that most of the nanospheres are retained in the heart and lungs. No accumulation in fetuses and placenta has been detected.
- 1 January 2024
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 94 (1) , 129-137
Synthesis of PLGA Nanoparticles Filled with Indocyanine Green and Warfarin for Biomedical Application, Study of Their Physical and Chemical Characteristics, Natural Biodistribution and Penetration through the Hematoplacental Barrier
Warfarin, the drug containing the chemical substance of the same name, currently is not prescribed to pregnant women because it crosses the hematoplacental barrier. This issue can be eliminated by incorporating it into polymer nanospheres. In this study, we have proposed a synthesis method and have characterized the prepared lactic-glycolic acid copolymer (PLGA) nanospheres containing warfarin (WAF) and the fluorescent dye Indocyanine Green (ICG). The optimal concentration of WAF has been established. The dependence of the nanospheres size on the reagents ratio has been investigated. The zeta potential values have been obtained, indicating high colloidal stability of the suspensions. The introduction of ICG into the nanospheres has afforded the data on their natural biodistribution. It has been found by means of fluorescence tomography that most of the nanospheres are retained in the heart and lungs. No accumulation in fetuses and placenta has been detected.
- Open Access
- 2 March 2023
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 9 (6) , 59-70
Direct comparison of KATUSHKA far-red fluorescent protein variants with luciferase bioluminescence in xenograft mouse models of epithelial tumor studies
Background. Research in oncology assumes establishment and usage of xenograft animal models, meeting the requirements of humanity and rationality. Although praised as promising field of research, preclinical studies of low-molecular-weight inhibitors, antitumor monoclonal antibodies, vaccines, cellular therapy products, CAR-T cells entail continuous control of tumor growth dynamics. Luciferase detection of bioluminescence requires injection of a reporter substrate. However, injections not only are laborious, time-consuming and expensive, but are also stressful for animals. Thus, a vast variety of new visualization methods is employed, including proteins of the far-red spectrum.Objective. The study aimed to compare detection efficiency of tumor growth dynamics in mice models of cervical cancer, applying a commercially available line of fluorescent red protein derivatives of Katushka clade and Renilla luciferase, that is commonly used in in vivo studies. Design and methods. Xenograft mice models were derived injecting modified HeLa cell line, that expresses fluorescent reporter proteins: Katushka, Katushka2S, TurboRFP, TurboFP650 and Renilla enzyme. Results. Spectral properties and emission wavelength of far-red fluorescent protein Katushka and Katushka2S outlines these markers within RFP derivatives lineage as outstanding instrument for in vivo tumor visualization.Conclusion. Detection of fluorescent far-red reporters Katushka and Katushka2S can be considered as a credible alternative to Renilla luciferase bioluminescence in experimental models in vivo on the part of immunotherapy research.
- 2 March 2023
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 9 (6) , 59-70
Open AccessDirect comparison of KATUSHKA far-red fluorescent protein variants with luciferase bioluminescence in xenograft mouse models of epithelial tumor studies
Background. Research in oncology assumes establishment and usage of xenograft animal models, meeting the requirements of humanity and rationality. Although praised as promising field of research, preclinical studies of low-molecular-weight inhibitors, antitumor monoclonal antibodies, vaccines, cellular therapy products, CAR-T cells entail continuous control of tumor growth dynamics. Luciferase detection of bioluminescence requires injection of a reporter substrate. However, injections not only are laborious, time-consuming and expensive, but are also stressful for animals. Thus, a vast variety of new visualization methods is employed, including proteins of the far-red spectrum.Objective. The study aimed to compare detection efficiency of tumor growth dynamics in mice models of cervical cancer, applying a commercially available line of fluorescent red protein derivatives of Katushka clade and Renilla luciferase, that is commonly used in in vivo studies. Design and methods. Xenograft mice models were derived injecting modified HeLa cell line, that expresses fluorescent reporter proteins: Katushka, Katushka2S, TurboRFP, TurboFP650 and Renilla enzyme. Results. Spectral properties and emission wavelength of far-red fluorescent protein Katushka and Katushka2S outlines these markers within RFP derivatives lineage as outstanding instrument for in vivo tumor visualization.Conclusion. Detection of fluorescent far-red reporters Katushka and Katushka2S can be considered as a credible alternative to Renilla luciferase bioluminescence in experimental models in vivo on the part of immunotherapy research.
- Open Access
- 16 April 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 6 (4) , ytac171
Reversible myocardial ischaemia caused by ectopic left circumflex coronary artery: a case report
Background: Coronary artery anomalies (CAAs) are congenital disorders associated with variable manifestations and pathophysiological mechanisms. Anomalies can be asymptomatic or cause chest pain, myocardial infarction, or even sudden cardiac death. Case summary: We describe a 34-year-old man with a history of a single episode of chest pain. An ectopic origin on the part of the left circumflex (LCX) coronary artery from the proximal right coronary artery (RCA) was evident upon coronary computed tomography angiography. A positron emission tomography perfusion study revealed a stress-induced perfusion defect in the anomalous LCX territory (infero-posterior wall). The patient experienced dyspnoea and ST-segment depression in electrocardiography, suggestive of myocardial ischaemia during the maximal bicycle ergometer stress test. No mechanical compression or stenosis was seen upon invasive coronary angiography. The left ventricular perfusion normalized after the initiation of beta-blocker medication. Discussion: Patients with CAAs especially benefit from a multimodality assessment of the vascular territories. In our case, the myocardial perfusion of the infero-posterior wall normalized after treatment with beta-blockers. This may be due to increased coronary vasodilation capacity and myocardial flow reserve, as well as reduced oxygen consumption. Beta-blockers may represent a viable option in low-symptomatic CAA patients with perfusion defect and no ostial stenosis or compression.
- 16 April 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 6 (4) , ytac171
Open AccessReversible myocardial ischaemia caused by ectopic left circumflex coronary artery: a case report
Background: Coronary artery anomalies (CAAs) are congenital disorders associated with variable manifestations and pathophysiological mechanisms. Anomalies can be asymptomatic or cause chest pain, myocardial infarction, or even sudden cardiac death. Case summary: We describe a 34-year-old man with a history of a single episode of chest pain. An ectopic origin on the part of the left circumflex (LCX) coronary artery from the proximal right coronary artery (RCA) was evident upon coronary computed tomography angiography. A positron emission tomography perfusion study revealed a stress-induced perfusion defect in the anomalous LCX territory (infero-posterior wall). The patient experienced dyspnoea and ST-segment depression in electrocardiography, suggestive of myocardial ischaemia during the maximal bicycle ergometer stress test. No mechanical compression or stenosis was seen upon invasive coronary angiography. The left ventricular perfusion normalized after the initiation of beta-blocker medication. Discussion: Patients with CAAs especially benefit from a multimodality assessment of the vascular territories. In our case, the myocardial perfusion of the infero-posterior wall normalized after treatment with beta-blockers. This may be due to increased coronary vasodilation capacity and myocardial flow reserve, as well as reduced oxygen consumption. Beta-blockers may represent a viable option in low-symptomatic CAA patients with perfusion defect and no ostial stenosis or compression.
- Open Access
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Protective effects of different types of bariatric surgeries on myocardial ischemia-reperfusion injury in non-obese non-diabetic rats
Introduction: Prior bariatric surgery (BS) significantly improves survival after myocardial infarction (MI). We assume that reduction in fatal MI after BSs could be attributed to the infarct size-limiting effect of the interventions and that this effect is not associated with an improvements in the diabetes mellitus and obesity. Purpose: The aim of the study was to evaluate the infarct-limiting effect of various types of bariatric surgery in non-obese non-diabetic rats. Methods: Rats were randomized into the following groups: no surgery (CON), sham surgery (SHAM), Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and ileal transposition (IT). 10 weeks after BS, the animals were subjected to ischemia-reperfusion, followed by histochemical determination of infarct area (IA) and no-reflow zone. At the 90th minute of reperfusion, all animals were injected intravenously with indocyanine green at a dose of 1 mg/kg to measure size of no-reflow zone. Results: None of bariatric surgery procedures led to body weight reduction. A temporal high postprandial glucose was observed during oral glucose tolerance test (OGTT) in SG and RYGB rats at 30th minute followed by decrease at 120 minutes in comparison with SHAM. Blood insulin concentration increased at 60th minutes in response to OGTT glucose in the SG group compared to CON and SHAM. On the contrary, there was a decrease in insulin level in the IT group after 60 and 120 minutes. In RYGB, basal leptin was low at 120 minutes after glucose administration, while in SG it decreased at 60 and 120 minutes compared with CON and SHAM. Compared to the SHAM, the rats with RYGB and SG had lower IA by 22% and 10% and no-reflow size by 38% and 32%. Conclusions: We demonstrated that both bariatric surgeries procedures, RYGB and SG, increase myocardial tolerance to ischemia-reperfusion injury in rats without diabetes and obesity. The infarct-limiting effect was accompanied by a significant decrease in basal plasma leptin level. Funding Acknowledgement: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Health Care of Russian Federation. Governmental funding research
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Open AccessProtective effects of different types of bariatric surgeries on myocardial ischemia-reperfusion injury in non-obese non-diabetic rats
Introduction: Prior bariatric surgery (BS) significantly improves survival after myocardial infarction (MI). We assume that reduction in fatal MI after BSs could be attributed to the infarct size-limiting effect of the interventions and that this effect is not associated with an improvements in the diabetes mellitus and obesity. Purpose: The aim of the study was to evaluate the infarct-limiting effect of various types of bariatric surgery in non-obese non-diabetic rats. Methods: Rats were randomized into the following groups: no surgery (CON), sham surgery (SHAM), Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and ileal transposition (IT). 10 weeks after BS, the animals were subjected to ischemia-reperfusion, followed by histochemical determination of infarct area (IA) and no-reflow zone. At the 90th minute of reperfusion, all animals were injected intravenously with indocyanine green at a dose of 1 mg/kg to measure size of no-reflow zone. Results: None of bariatric surgery procedures led to body weight reduction. A temporal high postprandial glucose was observed during oral glucose tolerance test (OGTT) in SG and RYGB rats at 30th minute followed by decrease at 120 minutes in comparison with SHAM. Blood insulin concentration increased at 60th minutes in response to OGTT glucose in the SG group compared to CON and SHAM. On the contrary, there was a decrease in insulin level in the IT group after 60 and 120 minutes. In RYGB, basal leptin was low at 120 minutes after glucose administration, while in SG it decreased at 60 and 120 minutes compared with CON and SHAM. Compared to the SHAM, the rats with RYGB and SG had lower IA by 22% and 10% and no-reflow size by 38% and 32%. Conclusions: We demonstrated that both bariatric surgeries procedures, RYGB and SG, increase myocardial tolerance to ischemia-reperfusion injury in rats without diabetes and obesity. The infarct-limiting effect was accompanied by a significant decrease in basal plasma leptin level. Funding Acknowledgement: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Health Care of Russian Federation. Governmental funding research
- 1 August 2021
- Published by Pleiades Publishing Ltd in Physics of the Solid State
- Vol. 63 (8) , 1276-1282
Composite Films Based on Carbon Quantum Dots in a Matrix of PEDOT:PSS Conductive Polymer
Carbon quantum dots (CQDs), as well as their composites with the PEDOT:PSS conductive polymer, are hydrothermally synthesized from glucose, and their electrical properties are investigated in the temperature range of 77–280 K. It is shown that the CQDs and PEDOT:PSS–CQDs films have a globular structure with globule sizes of ~50 nm. The dependences of the resistivity on temperature, ρ(T), are obtained for CQDs, PEDOT:PSS–CQDs, and PEDOT:PSS films, which have a weak activation character. It is found that the ρ values of the CQDs films are several orders of magnitude higher than the ρ values of PEDOT:PSS films. It is shown that with an increase in the CQDs content in the PEDOT:PSS–CQDs composites, the ρ(T) dependences exhibit a transition from high activation energies (∼17–18 meV) characteristic of pure PEDOT:PSS to lower values (∼10 meV) observed in CQDs films. The mechanism of transport of charge carriers in the investigated materials is considered.
- 1 August 2021
- Published by Pleiades Publishing Ltd in Physics of the Solid State
- Vol. 63 (8) , 1276-1282
Composite Films Based on Carbon Quantum Dots in a Matrix of PEDOT:PSS Conductive Polymer
Carbon quantum dots (CQDs), as well as their composites with the PEDOT:PSS conductive polymer, are hydrothermally synthesized from glucose, and their electrical properties are investigated in the temperature range of 77–280 K. It is shown that the CQDs and PEDOT:PSS–CQDs films have a globular structure with globule sizes of ~50 nm. The dependences of the resistivity on temperature, ρ(T), are obtained for CQDs, PEDOT:PSS–CQDs, and PEDOT:PSS films, which have a weak activation character. It is found that the ρ values of the CQDs films are several orders of magnitude higher than the ρ values of PEDOT:PSS films. It is shown that with an increase in the CQDs content in the PEDOT:PSS–CQDs composites, the ρ(T) dependences exhibit a transition from high activation energies (∼17–18 meV) characteristic of pure PEDOT:PSS to lower values (∼10 meV) observed in CQDs films. The mechanism of transport of charge carriers in the investigated materials is considered.
- Open Access
- 1 August 2021
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 5651-5664
Controlling the Movement of Magnetic Iron Oxide Nanoparticles Intended for Targeted Delivery of Cytostatics
Background: A promising approach to solve the problem of cytostatic toxicity is targeted drug transport using magnetic nanoparticles (MNPs). Purpose: To use calculation to determine the optimal characteristics of the magnetic field for controlling MNPs in the body, and to evaluate the efficiency of magnetically controlled delivery of MNPs in vitro and in vivo to a tumour site in mice. Material and Methods: For the in vitro study, reference MNPs were used, while for in vivo studies, MNPs coated in polylactide including fluorescent indocyanine (MNPs-ICG) were used. The in vivo luminescence intensity study was performed in mice with tumours, with and without of a magnetic field at the sites of interest. The studies were performed on a hydrodynamic stand developed at the Institute of Experimental Medicine of the Almazov National Medical Research Centre of the Ministry of Health of Russia. Results: The use of neodymium magnets facilitated selective accumulation of MNPs. One minute after the administration of MNPs-ICG to mice with a tumour, MNPs-ICG predominantly accumulated in the liver, in the absence and presence of a magnetic field, which indicates its metabolic pathway. The intensity of the fluorescence in the animals’ livers did not change over time, although an increase in fluorescence in the tumour was observed in the presence of a magnetic field. Conclusion: This type of MNP, used in combination with a magnetic field of calculated strength, can form the basis for the development of magnetically controlled transport of cytostatic drugs into tumour tissue.
- 1 August 2021
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 5651-5664
Open AccessControlling the Movement of Magnetic Iron Oxide Nanoparticles Intended for Targeted Delivery of Cytostatics
Background: A promising approach to solve the problem of cytostatic toxicity is targeted drug transport using magnetic nanoparticles (MNPs). Purpose: To use calculation to determine the optimal characteristics of the magnetic field for controlling MNPs in the body, and to evaluate the efficiency of magnetically controlled delivery of MNPs in vitro and in vivo to a tumour site in mice. Material and Methods: For the in vitro study, reference MNPs were used, while for in vivo studies, MNPs coated in polylactide including fluorescent indocyanine (MNPs-ICG) were used. The in vivo luminescence intensity study was performed in mice with tumours, with and without of a magnetic field at the sites of interest. The studies were performed on a hydrodynamic stand developed at the Institute of Experimental Medicine of the Almazov National Medical Research Centre of the Ministry of Health of Russia. Results: The use of neodymium magnets facilitated selective accumulation of MNPs. One minute after the administration of MNPs-ICG to mice with a tumour, MNPs-ICG predominantly accumulated in the liver, in the absence and presence of a magnetic field, which indicates its metabolic pathway. The intensity of the fluorescence in the animals’ livers did not change over time, although an increase in fluorescence in the tumour was observed in the presence of a magnetic field. Conclusion: This type of MNP, used in combination with a magnetic field of calculated strength, can form the basis for the development of magnetically controlled transport of cytostatic drugs into tumour tissue.
- Open Access
- 1 January 2021
- Published by Ioffe Institute Russian Academy of Sciences in Физика твердого тела
- Vol. 63 (8) , 1183
Композитные пленки на основе углеродных квантовых точек в матрице проводящего полимера PEDOT : PSS
Композитные пленки на основе углеродных квантовых точек в матрице проводящего полимера PEDOT : PSS
- 1 January 2021
- Published by Ioffe Institute Russian Academy of Sciences in Физика твердого тела
- Vol. 63 (8) , 1183
Open AccessКомпозитные пленки на основе углеродных квантовых точек в матрице проводящего полимера PEDOT : PSS
Композитные пленки на основе углеродных квантовых точек в матрице проводящего полимера PEDOT : PSS